Reporte de caso

← vista completa

Publicado el 23 de noviembre de 2022 | http://doi.org/10.5867/medwave.2022.10.2529

Primary gastric myofibroblastic tumor in an adult at Perú: Case report and literature review

Tumor miofibroblástico primario gástrico en un adulto en el Perú: reporte de caso y revisión de la literatura

Gustavo A. Flores-Trujillo , Milagros Abad-Licham, Sandro Casavilca-Zambrano, Hugo Valencia-Mariñas, Juan Astigueta-Pérez, Juan Díaz-Plasencia

Resumen

El tumor miofibroblástico inflamatorio primario gástrico es una neoplasia rara desarrollada de células madre mesenquimales, e infrecuentemente discutido en la literatura científica. El diagnóstico clínico a través de endoscopia y patología es desafiante para el equipo. Nosotros reportamos el caso de una paciente mujer con síndrome de obstrucción gástrica por un tumor de 10 cm diagnosticado con esta enfermedad usando histología e inmunohistoquímica.

Esta obra de Medwave está bajo una licencia Creative Commons Atribución-NoComercial 3.0 Unported. Esta licencia permite el uso, distribución y reproducción del artículo en cualquier medio, siempre y cuando se otorgue el crédito correspondiente al autor del artículo y al medio en que se publica, en este caso, Medwave.

Autores

Gustavo A. Flores-Trujillo

Universidad Privada Antenor Orrego, Trujillo, Perú

ttttavito@gmail.com

Las esmeraldas 580, Santa Inés, Trujillo, Perú

https://orcid.org/0000-0002-7428-411X

Milagros Abad-Licham

Universidad Privada Antenor Orrego, Trujillo, Perú

https://orcid.org/0000-0002-3530-6937

Sandro Casavilca-Zambrano

Instituto Nacional de Enfermedades Neoplásicas, Lima, Perú

https://orcid.org/0000-0001-8406-739X

Hugo Valencia-Mariñas

Universidad Privada Antenor Orrego, Trujillo, Perú

https://orcid.org/0000-0001-5360-9555

Juan Astigueta-Pérez

Universidad Privada Antenor Orrego, Trujillo, Perú

https://orcid.org/0000-0001-5984-3270

Juan Díaz-Plasencia

Universidad Privada Antenor Orrego, Trujillo, Perú

https://orcid.org/0000-0001-7019-6609

Figuras

Artículo no tiene figuras.

Foro

No hay mensajes

Historial

Citación Flores-Trujillo GA, Abad-Licham M, Casavilca-Zambrano S, Valencia-Mariñas H, Astigueta-Pérez J, Díaz-Plasencia J. Tumor miofibroblástico primario gástrico en un adulto en el Perú: reporte de caso y revisión de la literatura. Medwave 2022;22(10):e2529 doi: 10.5867/medwave.2022.10.2529

Envío 15/09/2021

Aceptación 15/07/2022

Publicación 23/11/2022

Indice

Métricas del artículo

Artículo no tiene métricas.

Notas

Palabras claves

Inflammatory myofibroblastic tumor, Stomach

Idioma del envío

Inglés.

Referencias

  1. Surabhi VR, Chua S, Patel RP, Takahashi N, Lalwani N, Prasad SR. Inflammatory Myofibroblastic Tumors: Current Update. Radiol Clin North Am. 2016;54: 553–63. | CrossRef | Link
  2. Gleason BC, Hornick JL. Inflammatory myofibroblastic tumours: where are we now? J Clin Pathol. 2008;61: 428–37. | CrossRef | Link
  3. Pettinato G, Manivel JC, De Rosa N, Dehner LP. Inflammatory myofibroblastic tumor (plasma cell granuloma). Clinicopathologic study of 20 cases with immunohistochemical and ultrastructural observations. Am J Clin Pathol. 1990;94: 538–46. | CrossRef | Link
  4. Na Y-S, Park S-G. Inflammatory myofibroblastic tumor of the pleura with adjacent chest wall invasion and metastasis to the kidney: a case report. J Med Case Rep. 2018;12. | CrossRef | Link
  5. Nakazato S, Yanagi T, Inamura Y, Kitamura S, Hata H, Shimizu H. Cutaneous inflammatory myofibroblastic tumour: a case report and literature review. Eur J Dermatol. 2017;27: 676–677. | CrossRef | Link
  6. Wang Y, Zhuang Y, Pan Y. Colonic Inflammatory Myofibroblastic Tumor. J Gastrointest Surg. 2021;25: 854–855. | CrossRef | Link
  7. El Hage Chehade HH, Zbibo RH, Abou Hussein BM, Abtar HK. Highly Vascularized Primarily Inflammatory Pseudotumor of the Omentum in an Adult Male: A Case Report. Am J Case Rep. 2016;17: 79–83. | CrossRef | Link
  8. Real Noval H, Fernández Fernández J, Castillo C. Á del. Masa abdominal de crecimiento rápido; tumor miofibroblástico inflamatorio. Gastroenterología y Hepatología. 2019;42: 259–260. | CrossRef | Link
  9. Monteiro L, Alhassani M, Resende T, Albuquerque R. Inflammatory myofibroblastic tumour of the jaw: A rare presentation. J Stomatol Oral Maxillofac Surg. 2020;121: 90–94. | CrossRef | Link
  10. Zhang Y, Peng C, Tian Z, Cao W, Yang X, Ji T. Inflammatory myofibroblastic tumor in the head and neck-a neoplasm with both tumor features and inflammation. Oral Surg Oral Med Oral Pathol Oral Radiol. 2020;130: e316–e323. | CrossRef | Link
  11. Kaur K, Yadav R, Dash NR, Madhusudan KS, Jangra K, Das P, et al. Synchronous Inflammatory Myofibroblastic Tumour of Liver and Carcinoma Head of Pancreas in a Young Male: a Diagnostic Dilemma. J Gastrointest Cancer. 2020;51: 620–623. | CrossRef | Link
  12. Mao X, Liu H, Du J, Yu N, Chen L, Zhang L. Imaging findings of inflammatory myofibroblastic tumor in breast: A case report. Medicine (Baltimore). 2018;97. | CrossRef | Link
  13. París-Sans M, Domènech-Calvet J, Raga-Carceller E, Sabench-Pereferrer F, del Castillo-Déjardin D. Tumor miofibroblástico inflamatorio gástrico como rara causa de obstrucción de la vía biliar. Cirugía Española. 2016;94: 188–190. | CrossRef | Link
  14. Murphy S, Shaw K, Blanchard H. Report of three gastric tumors in children. J Pediatr Surg. 1994;29: 1202–4. | CrossRef | Link
  15. Yache E. Reporte Hospitalario del Cancer 2007 al 2018. Trujillo. Peru: Instituto Regional de Enfermedades Neoplasicas del Norte; 2019.
  16. Prado-Cucho S, Huanca-Amesquita L. Inflammatory miofibroblastic tumor of the biliary tract in a pediatric patient. Rev Gastroenterol Peru. 2020;40: 284–287.
  17. López-IbarraS Calderón-Elvir C, Carrasco-Daza D, Medina-Vega A, Méndez-Martínez D. Tumor miofibroblástico inflamatorio gástrico Informe de un caso y revisión de la literatura. Rev Mex Cir Pediatr. 2007;14: 77–82.
  18. Lee JE, Choi S-Y, Lee HK, Yi BH, Lee MH, Lee S, et al. Computed tomographic features of inflammatory myofibroblastic tumour of the stomach in adult patients: An analysis of five multicentre cases with literature review. J Med Imaging Radiat Oncol. 2018;62: 769–776. | CrossRef | Link
  19. Cantera JE, Alfaro MP, Rafart DC, Zalazar R, Muruzabal MM, Barquín PG, et al. Inflammatory myofibroblastic tumours: a pictorial review. Insights Imaging. 2015;6: 85–96. | CrossRef | Link
  20. Humberto O. Tumor Miofibroblastico Inflamatorio (Pseudo tumor inflamatoria). Rev Chil Cir. 2014;66: 264–8. | Link
  21. Morales Prillwitz O, Pérez Hurtado B, Olaya Álvarez S, Arevalo Sánchez NM, Astudillo Palomino RE. Gastric inflammatory myofibroblastic tumor in A 10-month-old girl: A case report. Int J Surg Case Rep. 2020;68: 185–189. | CrossRef | Link
  22. Alloni R, Ancona G, Gallo I, Crescenzi A, Coppola R. Melena as presentation of primary small intestine inflammatory myofibroblastic tumor in an adult woman. A case report. Ann Ital Chir. 2015;86.
  23. Lee JY, Kim N. Diagnosis of Helicobacter pylori by invasive test: histology. Ann Transl Med. 2015;3: 10. | CrossRef | Link
  24. Cheng B, Yang C, Liu Z, Liu L, Zhou L. Primary gastric inflammatory myofibroblastic tumor: A case report. Medicine (Baltimore). 2018;97: 50. | CrossRef | Link
  25. Troncone E, Fugazza A, Cappello A, Del Vecchio Blanco G, Monteleone G, Repici A, et al. Malignant gastric outlet obstruction: Which is the best therapeutic option? World J Gastroenterol. 2020;26: 1847–1860. | CrossRef | Link
  26. Upchurch E, Ragusa M, Cirocchi R. Stent placement versus surgical palliation for adults with malignant gastric outlet obstruction. Cochrane Database Syst Rev. 2018;5: CD012506. | CrossRef | Link
  27. Panda S, Behera SS, Sarangi A. Malignant gastric outlet obstruction: a clinicopathological study in S. C B medical college hospital of Odisha, India. 2017. | Link
  28. Jadhav M, Harvi R, Patil R, Kittur S. Inflammatory Myofibroblastic Tumor of the Stomach Presenting as an Exophytic Mass - A Diagnostic Dilemma. Turk Patoloji Derg. 2019;35: 151–156. | CrossRef | Link
  29. Sun C-K. Gastric Inflammatory Myofibroblastic Tumor with Fludeoxyglucose (18F, FDG) Uptake on Positron Emission Tomography (PET): A Case Report and Literature Review. BJSTR. 2019;21: 16052–61. | CrossRef | Link
  30. Shi H, Wei L, Sun L, Guo A. Primary gastric inflammatory myofibroblastic tumor: a clinicopathologic and immunohistochemical study of 5 cases. Pathol Res Pract. 2010;206: 287–91. | CrossRef | Link
  31. Torres US, Matsumoto C, Maia DR, de Souza LRMF, D’Ippolito G. Computed Tomography and Magnetic Resonance Imaging Findings of Inflammatory Pseudotumors in the Abdomen and Pelvis: Current Concepts and Pictorial Review. Semin Ultrasound CT MR. 2018;39: 220–229. | CrossRef | Link
  32. Lovly CM, Gupta A, Lipson D, Otto G, Brennan T, Chung CT, et al. Inflammatory myofibroblastic tumors harbor multiple potentially actionable kinase fusions. Cancer Discov. 2014;4: 889–95. | CrossRef | Link
  33. Coffin CM, Patel A, Perkins S, Elenitoba-Johnson KS, Perlman E, Griffin CA. ALK1 and p80 expression and chromosomal rearrangements involving 2p23 in inflammatory myofibroblastic tumor. Mod Pathol. 2001;14: 569–76. | CrossRef | Link
  34. Qiu X, Montgomery E, Sun B. Inflammatory myofibroblastic tumor and low-grade myofibroblastic sarcoma: a comparative study of clinicopathologic features and further observations on the immunohistochemical profile of myofibroblasts. Hum Pathol. 2008;39: 846–56. | CrossRef | Link
  35. Salgueiredo-Giudice F, Fornias-Sperandio F, Martins-Pereira E, da Costa dal Vechio AM, de Sousa SCOM, dos Santos-Pinto-Junior D. The immunohistochemical profile of oral inflammatory myofibroblastic tumors. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011;111: 749–56. | CrossRef | Link
  36. Coffin CM, Hornick JL, Fletcher CDM. Inflammatory myofibroblastic tumor: comparison of clinicopathologic, histologic, and immunohistochemical features including ALK expression in atypical and aggressive cases. Am J Surg Pathol. 2007;31: 509–20. | CrossRef | Link
  37. Kataoka TR, Yamashita N, Furuhata A, Hirata M, Ishida T, Nakamura I, et al. An inflammatory myofibroblastic tumor exhibiting immunoreactivity to KIT: a case report focusing on a diagnostic pitfall. World J Surg Oncol. 2014;12. | CrossRef | Link
  38. Wang Y, Shen L, Yun T, Zhu C, Wang P, Wang S. Clinicopathological features of gastric inflammatory myofibroblastic tumor: Report of five cases. Exp Ther Med. 2021;22. | CrossRef | Link
  39. Muñoz Moya JE, Alfaro Aguirre MO, Leiva Silva M, Kakarieka Weisskopf E, López Sáez MT. Tumor miofibroblástico inflamatorio: presentación variable de una misma patología. Rev Chil Pediatr. 2019;90: 328. | CrossRef | Link
  40. Butrynski JE, D’Adamo DR, Hornick JL, Dal Cin P, Antonescu CR, Jhanwar SC, et al. Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor. N Engl J Med. 2010;363: 1727–33. | CrossRef | Link
  41. Hussong JW, Brown M, Perkins SL, Dehner LP, Coffin CM. Comparison of DNA ploidy, histologic, and immunohistochemical findings with clinical outcome in inflammatory myofibroblastic tumors. Mod Pathol. 1999;12: 279–86.